Earnings Feed
Start Free
Esperion Therapeutics, Inc.·4

Jun 2, 4:07 PM ET

VITULLO NICOLE 4

4 · Esperion Therapeutics, Inc. · Filed Jun 2, 2025

Insider Transaction Report

Form 4
Period: 2025-05-29
Esperion Therapeutics, Inc.ESPR
VITULLO NICOLE
Director10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2025-05-29+88,000→ 88,000 total
    Exercise: $0.87Exp: 2035-05-29→ Common Stock (88,000 underlying)
Footnotes (1)
  • [F1]The awards vest in full on the earlier of (i) May 29, 2026 and (ii) the Issuer's next annual meeting of stockholders following May 29, 2025.

Documents

2 files